60 Share Price

60 Share Price

NASDAQ: SXTP | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

60 Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
$0.40 - $8.22
Volume
N/A
Average Traded
N/A

60 Share Price Chart

Line chart of the 60 price trend over the selected period. The price rose overall, ranging from 0.51 to 0.53, ending at 0.53.
$0.00$0.00
L
Show Current Price
H

60 Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.92
Revenue (TTM)
$1.41B
Return On Equity (TTM)
-329.59%
Profit Margin
-557.45%
Debt to Equity
0.06
Quarterly Earnings Growth YoY
-70.70%

60 Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.32$0.16$0.21$0.23
Net Profit-$1.57-$2.21-$2.40-$2.68
Net Profit Margin-490.63%-1381.25%-1142.86%-1165.22%
Income ChangeN/A-40.76%-8.60%-11.67%

60 Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.25$0.68$1.41
Net Profit-$3.92-$8.43-$7.86
Net Profit Margin-1568.00%-1239.71%-557.45%
Income ChangeN/A-115.05%6.76%

60 Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets0.470.370.54
Current Assets4.95.397.24
Total Assets5.375.767.78
Non Current Liabilities0.140.150.15
Current Liabilities1.851.662.84
Total Liabilities1.991.82.99
Shareholders' Equity3.383.964.8

60 Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-6.85-5.65-4.54
Investing0.25-1.89-0.12
Financing6.447.056.47

Corporate Actions

Split
Ex-date: 20 Jan 2026

Split
Ex-date: 24 Feb 2025

Split
Ex-date: 12 Aug 2024

About 60

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

60 Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.90
$0.53
-42.31%
Oct 2026
$1.28
$0.91
-24.17%
Sep 2026
$1.06
$1.20
+12.68%
Aug 2026
$1.14
$1.06
-4.48%
Jul 2026
$1.87
$1.11
-30.75%
Jun 2026
$1.49
$1.61
+7.69%
May 2026
$1.67
$1.50
-5.68%
Apr 2026
$1.74
$1.58
-8.65%
Mar 2026
$2.72
$1.74
-40.38%
Feb 2026
$3.62
$2.91
-31.37%
Jan 2026
$0.52
$4.24
+733.01%
Dec 2025
$1.09
$0.51
-48.59%

60 Share Price FAQs